NTRX-07
Alzheimer's Disease
Key Facts
About NeuroTherapia
NeuroTherapia is a private, clinical-stage biotech advancing an oral, small molecule CB2 receptor agonist, NTRX-07, to treat neuroinflammatory conditions like Alzheimer's Disease (AD) and neuropathic pain. The company, a Cleveland Clinic spin-out founded in 2009, has completed Phase 1 studies showing safety and a trend toward cognitive improvement in AD, with a Phase 2 trial planned for 2024. NeuroTherapia is backed by venture capital, foundations, and state grants, positioning it to explore a novel anti-inflammatory mechanism that could complement existing protein-targeting therapies in the challenging CNS market.
View full company profileAbout NeuroTherapia
NeuroTherapia is a private, clinical-stage biotech advancing an oral, small molecule CB2 receptor agonist, NTRX-07, to treat neuroinflammatory conditions like Alzheimer's Disease (AD) and neuropathic pain. The company, a Cleveland Clinic spin-out founded in 2009, has completed Phase 1 studies showing safety and a trend toward cognitive improvement in AD, with a Phase 2 trial planned for 2024. NeuroTherapia is backed by venture capital, foundations, and state grants, positioning it to explore a novel anti-inflammatory mechanism that could complement existing protein-targeting therapies in the challenging CNS market.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NUZ-001 | Neurizon Therapeutics | Preclinical |
| ALZN002 | Alzamend Neuro | Preclinical |
| P021 | Phanes Biotech | Preclinical |
| PB43D | Phanes Biotech | Preclinical |
| UB-311 | Vaxxinity | Phase 2 |
| Lecanemab | BioArctic | Launched |
| BAN2401 | BioArctic | Preclinical |
| Undisclosed Programs | johnson-and-johnson-innovative-medicine | Pipeline |
| MK-6240 (florquinitau) | Lantheus Medical Imaging | Regulatory Filing |
| NAV-4694 (flutafuranol) | Lantheus Medical Imaging | Phase 3 |
| LNTH-2620/PI-2620 | Lantheus Medical Imaging | Phase 3 |
| itMSCs | Stemedica Cell Technologies | Clinical Development |